8-K
filed June 16, 2023, 7:59 PM ET
ticker KIDS
CIK 0001425450
other
confidence high
sentiment neutral
materiality 0.10
All four stockholder proposals approved at OrthoPediatrics 2023 annual meeting
ORTHOPEDIATRICS CORP
- Directors elected: Dyer (20.2M for), Pelizzon (15.7M for, 4.7M withheld), Ruf (15.7M for), Schlotterback (14.4M for).
- Advisory say-on-pay approved with 19.2M for, 1.1M against, 60.9K abstain.
- Stockholders recommended annual say-on-pay frequency (11.3M votes for 1 year vs 8.8M for 3 years).
- Deloitte & Touche ratified as independent auditor for FY2023 with 21.3M for, 21.6K against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORTHOPEDIATRICS CORP shareholders approved Election of Directors at the 2023-06-14 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The nominees below were elected to serve as directors for a term that will last until the Company’s 2026 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORTHOPEDIATRICS CORP shareholders approved Approval, on an advisory basis, of the compensation of the Company's named executive officers at the 2023-06-14 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The Company's stockholders approved the compensation of the Company's named executive officers by voting as follows: For Against Abstain Broker Non-Votes 19,169,777 1,077,595 60,927 981,776
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORTHOPEDIATRICS CORP shareholders approved Selection, on an advisory basis, of the frequency of future advisory votes on executive compensation at the 2023-06-14 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
As reflected below, a majority of the votes cast advised that the vote on executive compensation should occur every year.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ORTHOPEDIATRICS CORP shareholders approved Approval, on an advisory basis, of the appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for our Fiscal Year Ending December 31, 2023 at the 2023-06-14 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-14
Exact text from the filing
The Company’s stockholders approved the appointment by the Audit Committee of the Company’s Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 by voting as follows: For Against Abstain 21,268,308 21,630 137
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.